Descriptor English: | Thiamine Triphosphate | ||||
Descriptor Spanish: |
Tiamina Trifosfato
| ||||
Descriptor Portuguese: | Tiamina Trifosfato | ||||
Descriptor French: | Triphosphate de thiamine | ||||
Entry term(s): |
Thiamin Triphosphate Triphosphate, Thiamin Triphosphate, Thiamine |
||||
Tree number(s): |
D02.886.675.900.900 D03.383.129.708.900.900 D03.383.742.795.900 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D013838 | ||||
Scope note: | 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(4,6,8,8-tetrahydroxy-3,5,7-trioxa-4,6,8-triphosphaoct-1-yl)thiazolium hydroxide, inner salt, P,P',P''-trioxide. The triphosphate ester of thiamine. In Leigh's disease, this compound is present in decreased amounts in the brain due to a metabolic block in its formation. |
||||
Annotation: | do not confuse with THIAMIN TRIPHOSPHATASE; deficiency: coordinate THIAMINE TRIPHOSPHATE /defic (IM) with THIAMINE DEFICIENCY (IM) |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Vitamin B Complex |
||||
Registry Number: | 3475-65-8 | ||||
CAS Type 1 Name: | Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(4,6,8,8-tetrahydroxy-3,5,7-trioxa-4,6,8-triphosphaoct-1-yl)-, inner salt, P,P',P''-trioxide | ||||
Previous Indexing: |
Organophosphorus Compounds (1971-1978) Thiamine (1966-1978) |
||||
Public MeSH Note: | 91; was see under THIAMINE 1979-90 |
||||
History Note: | 91(79); was see under THIAMINE 1979-90 |
||||
DeCS ID: | 14216 | ||||
Unique ID: | D013838 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1991/01/01 | ||||
Date of Entry: | 1977/12/22 | ||||
Revision Date: | 2016/06/01 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Thiamine Triphosphate
- Preferred
Concept UI |
M0021326 |
Scope note | 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(4,6,8,8-tetrahydroxy-3,5,7-trioxa-4,6,8-triphosphaoct-1-yl)thiazolium hydroxide, inner salt, P,P',P''-trioxide. The triphosphate ester of thiamine. In Leigh's disease, this compound is present in decreased amounts in the brain due to a metabolic block in its formation. |
Preferred term | Thiamine Triphosphate |
Entry term(s) |
Thiamin Triphosphate Triphosphate, Thiamin Triphosphate, Thiamine |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey